Late-Onset Agoraphobia: General Population Incidence and Evidence for a Clinical Subtype
Abstract
Objective
Method
Results
Conclusions
Method
Sample
Measures
Standardized health interview.
Standardized clinical examination.
Standardized psychiatric interview.
Cognitive functioning.
Childhood environment.
Statistical Analysis
Results
Variable | Total (N=1,968) (%) | Agoraphobia | p | |
---|---|---|---|---|
Absent (N=1,764) (%) | Present (N=204) (%) | |||
Age (years) | 0.22 | |||
65–69 | 31.66 | 31.52 | 32.84 | |
70–74 | 35.37 | 34.81 | 40.20 | |
75–79 | 21.34 | 21.77 | 17.65 | |
≥80 | 11.64 | 11.90 | 9.31 | |
Sex | <0.001 | |||
Male | 41.77 | 43.65 | 25.49 | |
Female | 58.23 | 56.35 | 74.51 | |
Education level | 0.01 | |||
Low | 23.63 | 23.19 | 27.45 | |
Average | 29.17 | 28.23 | 37.25 | |
High | 47.21 | 48.58 | 35.29 | |
Body mass index | 0.84 | |||
<25 | 53.79 | 53.49 | 56.37 | |
25–29 | 37.91 | 38.16 | 35.78 | |
≥30 | 8.30 | 8.35 | 7.84 | |
Regular use of anti-inflammatory drugs for joint or back pain | 0.08 | |||
No | 87.74 | 87.40 | 90.69 | |
Yes | 12.26 | 12.60 | 9.31 | |
Hypertension (resting blood pressure ≥160/95 mmHg) or treated hypertension | 0.96 | |||
No | 55.18 | 55.05 | 56.37 | |
Yes | 44.82 | 44.95 | 43.63 | |
Cholesterol (quartiles) | 0.02 | |||
Lowest | 50.87 | 50.60 | 53.23 | |
Middle two | 25.05 | 26.16 | 15.42 | |
Highest | 24.08 | 23.24 | 31.34 | |
Diabetes (glycemia ≥7 mmol/L) or treated diabetes | 0.61 | |||
No | 91.02 | 91.01 | 91.09 | |
Yes | 8.98 | 8.99 | 8.91 | |
Respiratory problems (dyspnea, asthma, or bronchitis) | 0.006 | |||
No | 85.95 | 86.71 | 79.41 | |
Yes | 14.05 | 13.29 | 20.59 | |
Stroke | 0.90 | |||
No | 97.29 | 97.20 | 98.03 | |
Yes | 2.71 | 2.80 | 1.97 | |
Cardio- and cerebrovascular pathologies | 0.56 | |||
No | 76.68 | 76.64 | 76.96 | |
Yes | 23.32 | 23.36 | 23.04 | |
Osteoporosis monitoring | 0.17 | |||
No | 81.46 | 82.41 | 73.27 | |
Yes | 18.54 | 17.59 | 26.73 | |
Hospitalization for cancer (past 2 years) | 0.10 | |||
No | 98.58 | 98.70 | 97.55 | |
Yes | 1.42 | 1.30 | 2.45 | |
Chronic pathologies (number) | 0.11 | |||
0 | 36.74 | 36.90 | 35.29 | |
1–2 | 57.06 | 57.20 | 55.88 | |
≥3 | 6.20 | 5.90 | 8.82 | |
Benton Visual Retention Test score (lowest tertile) | 0.22 | |||
No | 61.48 | 62.21 | 55.17 | |
Yes | 38.52 | 37.79 | 44.83 | |
Isaacs Set Test score (lowest tertile, at 30 seconds) | 0.01 | |||
No | 67.79 | 68.74 | 59.50 | |
Yes | 32.21 | 31.26 | 40.50 | |
Hearing or visual deficiency | 0.93 | |||
No | 89.29 | 89.26 | 89.53 | |
Yes | 10.71 | 10.74 | 10.47 | |
Depressive symptoms | <0.001 | |||
None | 69.78 | 71.39 | 55.94 | |
Mild | 16.24 | 16.23 | 16.34 | |
Severe | 13.98 | 12.39 | 27.72 | |
History of major depression | 0.02 | |||
No | 74.82 | 75.87 | 65.67 | |
Yes | 25.18 | 24.13 | 34.33 | |
Spielberger trait anxiety scale score (highest tertile) | <0.001 | |||
No | 69.24 | 70.87 | 55.05 | |
Yes | 30.76 | 29.13 | 44.95 | |
Confinement (to bed, home, or neighborhood) | 0.35 | |||
No | 94.95 | 95.11 | 93.60 | |
Yes | 5.05 | 4.89 | 6.40 | |
Mobility limitation | 0.001 | |||
No | 61.69 | 63.10 | 49.50 | |
Yes | 38.31 | 36.90 | 50.50 | |
Incapacity for activities of daily living | 0.27 | |||
No | 96.01 | 96.17 | 94.58 | |
Yes | 3.99 | 3.83 | 5.42 | |
Falls (past months) | 0.002 | |||
No | 80.17 | 81.23 | 71.08 | |
Yes | 19.83 | 18.77 | 28.92 | |
Serious life event (at least one) | 0.43 | |||
No | 41.08 | 40.85 | 43.23 | |
Yes | 58.92 | 59.15 | 56.77 |
Variable | Two-Year Follow-Up (N=1,376)a | Four-Year Follow-Up (1,260)a | Analysis (N=1,461)a | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | Odds Ratiob | 95% CI | p | |
Sex | |||||||
Male | 623 | 5.94 | 563 | 5.33 | 1.00 | ||
Female | 753 | 7.57 | 697 | 7.75 | 1.45 | 0.94–2.23 | 0.09 |
Education level | |||||||
Low | 291 | 9.62 | 272 | 4.04 | 1.00 | ||
Average | 381 | 6.30 | 350 | 10.0 | 0.82 | 0.45–1.47 | 0.50 |
High | 703 | 5.97 | 638 | 5.96 | 1.20 | 0.70–2.08 | 0.50 |
Body mass index | |||||||
<25 | 738 | 6.78 | 680 | 7.21 | 1.00 | ||
25–29 | 522 | 7.85 | 478 | 5.86 | 0.99 | 0.64–1.55 | 0.99 |
≥30 | 108 | 1.85 | 96 | 6.25 | 0.46 | 0.18–1.19 | 0.10 |
Regular use of anti-inflammatory drugs for joint or back pain | |||||||
No | 1,206 | 6.88 | 1,097 | 6.93 | 1.00 | ||
Yes | 161 | 5.59 | 155 | 4.52 | 0.69 | 0.34–1.39 | 0.30 |
Hypertension (resting blood pressure ≥160/95 mmHg) or treated hypertension | |||||||
No | 765 | 7.97 | 703 | 7.54 | 1.00 | ||
Yes | 611 | 5.40 | 557 | 5.57 | 0.69 | 0.44–1.07 | 0.10 |
Cholesterol (quartiles) | |||||||
Lowest | 697 | 7.03 | 640 | 6.72 | 1.00 | ||
Middle two | 343 | 6.12 | 316 | 7.28 | 1.05 | 0.62–1.79 | 0.84 |
Highest | 327 | 7.34 | 297 | 6.06 | 1.02 | 0.55–1.88 | 0.95 |
Diabetes (glycemia ≥7 mmol/L) or treated diabetes | |||||||
No | 1,246 | 6.42 | 1,144 | 6.82 | 1.00 | ||
Yes | 120 | 11.67 | 108 | 5.56 | 1.54 | 0.77–3.08 | 0.22 |
Respiratory problems (dyspnea, asthma, or bronchitis) | |||||||
No | 1,221 | 6.55 | 1,119 | 6.70 | 1.00 | ||
Yes | 150 | 9.33 | 133 | 6.77 | 1.50 | 0.78–2.85 | 0.22 |
Stroke | |||||||
No | 1,332 | 6.61 | 1,220 | 6.56 | 1.00 | ||
Yes | 34 | 11.76 | 30 | 6.67 | 2.07 | 0.59–7.24 | 0.25 |
Cardio- and cerebrovascular pathologies | |||||||
No | 1,073 | 6.62 | 979 | 7.05 | 1.00 | ||
Yes | 303 | 7.59 | 281 | 5.34 | 1.08 | 0.64–1.81 | 0.77 |
Osteoporosis monitoring | |||||||
No | 1,132 | 7.16 | 1,037 | 6.65 | 1.00 | ||
Yes | 230 | 5.22 | 212 | 7.08 | 0.82 | 0.45–1.47 | 0.50 |
Hospitalization for cancer (past 2 years) | |||||||
No | 1,363 | 6.82 | 1,246 | 6.66 | 1.00 | ||
Yes | 13 | 7.69 | 14 | 7.14 | 1.23 | 0.18–9.42 | 0.80 |
Number of chronic pathologies | |||||||
0 | 525 | 6.67 | 477 | 6.71 | 1.00 | ||
1–2 | 781 | 6.91 | 723 | 6.78 | 1.18 | 0.74–1.85 | 0.48 |
≥3 | 70 | 7.14 | 60 | 5.00 | 1.15 | 0.41–3.25 | 0.79 |
Benton Visual Retention Test score (lowest tertile) | |||||||
No | 880 | 5.68 | 799 | 6.51 | 1.00 | ||
Yes | 484 | 8.68 | 451 | 7.10 | 1.53 | 0.98–2.39 | 0.06 |
Isaacs Set Test score (lowest tertile, at 30 seconds) | |||||||
No | 912 | 6.47 | 841 | 6.42 | 1.00 | ||
Yes | 440 | 7.73 | 398 | 7.04 | 1.26 | 0.81–1.98 | 0.30 |
Hearing or visual deficiency | |||||||
No | 1,164 | 6.79 | 1,074 | 6.89 | 1.00 | ||
Yes | 123 | 8.13 | 109 | 3.67 | 0.94 | 0.44–2.01 | 0.87 |
Depressive symptoms | |||||||
None | 1,005 | 5.17 | 922 | 6.18 | 1.00 | ||
Mild | 206 | 5.83 | 190 | 7.37 | 1.29 | 0.71–2.36 | 0.41 |
Severe | 148 | 17.57 | 133 | 9.02 | 3.81 | 2.08–6.97 | <0.001 |
History of major depression | |||||||
No | 1,066 | 6.10 | 981 | 6.01 | 1.00 | ||
Yes | 299 | 9.03 | 269 | 8.92 | 1.70 | 1.05–2.74 | 0.03 |
Spielberger trait anxiety scale score (highest tertile) | |||||||
No | 967 | 5.27 | 896 | 5.47 | 1.00 | ||
Yes | 387 | 10.59 | 347 | 10.09 | 2.48 | 1.58–3.90 | <0.001 |
Confinement (to bed, home, or neighborhood) | |||||||
No | 1,341 | 6.71 | 1,218 | 6.81 | 1.00 | ||
Yes | 30 | 10.00 | 38 | 2.63 | 1.11 | 0.27–4.64 | 0.88 |
Mobility limitation | |||||||
No | 5.55 | 901 | 5.83 | 823 | 1.00 | ||
Yes | 8.74 | 446 | 8.29 | 410 | 2.33 | 1.43–3.81 | <0.001 |
Incapacity for activities of daily living | |||||||
No | 1,333 | 6.68 | 1,211 | 6.69 | 1.00 | ||
Yes | 32 | 12.50 | 37 | 5.41 | 1.82 | 0.53–6.19 | 0.34 |
Falls (past months) | |||||||
No | 1,113 | 6.56 | 1,026 | 7.12 | 1.00 | ||
Yes | 258 | 7.75 | 230 | 4.78 | 0.98 | 0.56–1.7 | 0.95 |
Serious life event (at least one) | |||||||
No | 560 | 6.79 | 505 | 5.74 | 1.00 | ||
Yes | 787 | 6.86 | 723 | 7.47 | 1.26 | 0.81–1.97 | 0.30 |
Discussion
Prevalence, Incidence, and Comorbidity
Risk Factors
References
Information & Authors
Information
Published In
History
Authors
Author Contributions
Funding Information
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).